catalyst

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and — primary completion

as of 2026-07-01
at a glance
2025-08-15 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and — primary completion
Type
Trial Readout
Date
2025-08-15
Date type
ACTUAL
Phase
Phase 3
This event happened.